> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CyMedica Ortho’s Knee Pain Neuromodulator Cleared
- URL: https://www.fdaweb.com/cymedica-orthos-knee-pain-neuromodulator-cleared/
- Published: 2021-06-09T12:00:00.000Z
- Updated: 2026-09-14T17:02:20.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5149502

FDA has cleared a CyMedica Orthopedics 510(k) for its IntelliHab for managing knee osteoarthritis pain. The device delivers neuromodulation strengthening therapy to treat pain associated with osteoarthritis. The individualized muscle stimulation is intended to reduce muscle weakness, “while keeping patients proactive in therapy through an intuitive app-driven interface,” the company says. “The IntelliHab app connects patients to healthcare providers by communicating critical data in measuring progress to a secure portal, where providers can remotely monitor and motivate patients in real-time,” it adds.

Clearance was based on data from a recent randomized, sham-controlled, double-blind, multicenter study designed to evaluate the efficacy and safety of IntelliHab in knee osteoarthritis patients. The data showed that the device contributed to significant pain reduction and improved mobility, CyMedica says.